Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 2Breast Neoplasms 2Rectal Neoplasms 1Motor Activity 1Lung Neoplasms 1Hodgkin Disease 1Digestive System Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Cholecalciferol 4Nutrition Assessment 3Exercise 3Blood Pressure 3Atorvastatin 3acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Vitamin E 2Vitamin D 2Rosuvastatin Calcium 2Methods 2Metformin 2Gonadotropin-Releasing Hormone 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Educational Status 2Diet, Mediterranean 2Aspirin 2xinmailong 1sofosbuvir-velpatasvir drug combination 1pembrolizumab 1palbociclib 1ficlatuzumab 1beta Carotene 1amlodipine, atorvastatin drug combination 1Vorinostat 1Vitamin B 6 1Vitamin B 12 1Tumor Necrosis Factor Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cardiovascular Diseases × Physical Conditioning, Human × Clear all
NCT04636255 2026-05-04

Physical Capacity in Hodgkin Lymphoma Survivors

University of Sao Paulo General Hospital

Phase NA Completed
40 enrolled
Lymphoid

Cardiovascular Diseases, Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡